[HTML][HTML] Therapeutic management of patients with COVID-19: a systematic review

M Tobaiqy, M Qashqary, S Al-Dahery… - Infection Prevention in …, 2020 - Elsevier
Background Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the
causative agent of coronavirus disease 2019 (COVID-19), which was declared a global …

Current treatments and therapeutic options for COVID-19 patients: a systematic review

E Mehraeen, Z Najafi, B Hayati… - … Current Drug Targets …, 2022 - ingentaconnect.com
Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into
a worldwide pandemic. Many clinical studies have been achieved to investigate treatments …

Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications

AR Abubakar, IH Sani, B Godman… - Infection and drug …, 2020 - Taylor & Francis
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

[HTML][HTML] Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

[HTML][HTML] Treatments administered to the first 9152 reported cases of COVID-19: a systematic review

DC Fajgenbaum, JS Khor, A Gorzewski… - Infectious diseases and …, 2020 - Springer
The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global
pandemic with no approved treatments or vaccines. Many treatments have already been …

[HTML][HTML] Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis

MS Kim, MH An, WJ Kim, TH Hwang - PLoS medicine, 2020 - journals.plos.org
Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …

[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …

Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)

A Bhimraj, RL Morgan, AH Shumaker… - Clinical Infectious …, 2020 - academic.oup.com
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …